FRPTAugust 5, 2026 at 10:30 AM UTCFood, Beverage & Tobacco

Freshpet Q2 2026: ~15% Sales Growth, Raised Outlook, and >49% Long-Term Gross Margin Target

Read source article

What happened

Freshpet reported Q2 2026 net sales growth of approximately 15%, exceeding prior expectations and prompting an upward revision to its full-year 2026 revenue and adjusted EBITDA guidance. The company also updated its long-term adjusted gross margin target to over 49%, up from the previous 48%, signaling confidence in sustained profitability improvements from scale and operational efficiencies. These results address a key concern from the prior investment thesis—that growth might decelerate below low-teens amid competitive pressure—though it remains to be seen if this pace is durable with Blue Buffalo’s fresh rollout underway. The raised margin target supports the bull case by extending the runway for operating leverage beyond prior expectations. However, the stock’s reaction may already embed much of this good news, and the underlying risks around competition and capital intensity haven’t been eliminated, keeping the risk-reward balanced but slightly improved.

Implication

Freshpet’s Q2 outperformance and updated outlook strengthen the operational thesis, suggesting the company can deliver low-teens growth and expand margins beyond prior targets. The >49% long-term gross margin goal indicates that management sees additional levers for cost efficiency and pricing power. This could push the base-case implied value above the prior $80 per share, especially if EBITDA margins trend toward 22%+. However, the stock may have already repriced following the announcement, and we need to assess the competitive response from Blue Buffalo and retailer shelf-space dynamics over the next few quarters. For now, the improved outlook reduces downside risk but hasn’t fully shifted the balance away from a wait-and-see posture.

Thesis delta

The previous thesis was WAIT with a base-case value of $80 and an attractive entry at $60, hinging on sustained growth and margin expansion. The Q2 results and raised guidance push growth and margin expectations higher, supporting a bull-case trajectory. While the competitive overhang remains, the operational momentum increases conviction and tilts the risk-reward toward the upper end of the range, warranting a reassessment with a bias toward upgrading if the next few quarters confirm durability.

Confidence

High